famotidine has been researched along with Chemotherapy-Induced Acral Erythema in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Excerpt | Relevance | Reference |
---|---|---|
"Member institutions of the Japan Breast Cancer Research Group were invited to complete a questionnaire on the occurrence of grade 2 or higher HFS and FE among patients treated between April 2007 and March 2008 with docetaxel as an adjuvant or neoadjuvant chemotherapeutic treatment for breast cancer." | 1.37 | Correlation between docetaxel-induced skin toxicity and the use of steroids and H₂ blockers: a multi-institution survey. ( Aogi, K; Ishiguro, H; Iwata, H; Kawaguchi, K; Kuroi, K; Masuda, N; Morita, S; Nakamura, S; Ohno, S; Toi, M, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kawaguchi, K | 1 |
Ishiguro, H | 1 |
Morita, S | 1 |
Nakamura, S | 1 |
Ohno, S | 1 |
Masuda, N | 1 |
Iwata, H | 1 |
Aogi, K | 1 |
Kuroi, K | 1 |
Toi, M | 1 |
1 other study available for famotidine and Chemotherapy-Induced Acral Erythema
Article | Year |
---|---|
Correlation between docetaxel-induced skin toxicity and the use of steroids and H₂ blockers: a multi-institution survey.
Topics: Acetamides; Breast Neoplasms; Chemotherapy, Adjuvant; Dexamethasone; Docetaxel; Erythema; Famotidine | 2011 |